Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin

被引:0
|
作者
Gunn, Nadege T. [1 ]
Ling, Lei [2 ]
Neff, Guy [3 ]
Guy, Cynthia [4 ]
Bashir, Mustafa [4 ]
Paredes, Angelo [5 ]
Frias, Juan [6 ]
Younes, Ziad H. [7 ]
Trotter, James F. [8 ]
Moussa, Sam [9 ]
Kohli, Anita [10 ]
Connelly, Margery A. [11 ]
Nelson, Kristen [2 ]
Gottwald, Mildred [2 ]
Chang, William [2 ]
Yan, Andrew [2 ]
DePaoli, Alex [2 ]
Lieu, Hsiao [2 ]
Harrison, Stephen [12 ]
机构
[1] Pinnacle Clin Res, Austin, TX USA
[2] NGM Biopharmaceut, San Francisco, CA USA
[3] Covenant Res & Clin, Ft Myers, FL USA
[4] Duke Univ, Durham, NC 27706 USA
[5] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA
[6] Natl Res Inst, Los Angeles, CA USA
[7] Gastro One Res, Germantown, TN USA
[8] Texas Digest Dis Consultants, Dallas, TX USA
[9] Adobe Clin Res, Tucson, AZ USA
[10] Arizona Liver Hlth, Chandler, AZ USA
[11] Labcorp, Morrisville, NC USA
[12] Pinnacle Clin Res, San Antonio, TX USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PO-1082
引用
收藏
页码:S617 / S617
页数:1
相关论文
共 50 条
  • [21] Cardiovascular and Glycemic Benefits of Bexagliflozin as an Adjunct to Metformin for the Treatment of Type 2 Diabetes in Adults: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Halvorsen, Yuan-Di C.
    Lock, John P.
    Freeman, Mason W.
    DIABETES, 2020, 69
  • [22] Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    DIABETES CARE, 2014, 37 (06) : 1650 - 1659
  • [23] Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trial
    Halvorsen, Yuan-Di
    Conery, Annie L.
    Lock, John Paul
    Zhou, Wenjiong
    Freeman, Mason W.
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2954 - 2962
  • [24] EFFECT OF SECUKINUMAB ON SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS OF A 24-WEEK MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    McInnes, Iain
    Sieper, Joachim
    Braun, Juergen
    Emery, Paul
    van der Heijde, Desiree
    Isaacs, John
    Dahmen, Georg
    Wollenhaupt, Juergen
    Schulze-Koops, Hendrik
    Gsteiger, Sandro
    Bertolino, Arthur
    Hueber, Wolfgang
    Tak, Paul P.
    RHEUMATOLOGY, 2012, 51 : 90 - 91
  • [25] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
    Simpson, Richard W.
    Nicholson, Geoffrey C.
    Proietto, Joseph
    Sarah, Alana
    Sanders, Kerrie M.
    Phillips, Gabrielle
    Chambers, Jo
    MacGinley, Rob
    Orford, Neil
    Walder, Ken
    Krippner, Guy
    Skoff, Kathy
    Wacher, Vincent J.
    DIABETES CARE, 2014, 37 (11) : 3121 - 3123
  • [26] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Kohji Shirai
    Toru Fujita
    Michitaka Tanaka
    Yuka Fujii
    Masatsugu Shimomasuda
    Soichi Sakai
    Yoshishige Samukawa
    Advances in Therapy, 2019, 36 : 86 - 100
  • [27] Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
    Roman, GC
    Pratt, RD
    Perdomo, CA
    Perdomo, CA
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S55 - S55
  • [28] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Shirai, Kohji
    Fujita, Toru
    Tanaka, Michitaka
    Fujii, Yuka
    Shimomasuda, Masatsugu
    Sakai, Soichi
    Samukawa, Yoshishige
    ADVANCES IN THERAPY, 2019, 36 (01) : 86 - 100
  • [29] EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY
    Allanore, Y.
    Wung, P.
    Soubrane, C.
    Esperet, C.
    Frederic, M.
    Bejuit, R.
    Lahmar, A.
    Khanna, D.
    Denton, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 157 - 158
  • [30] Comment on "Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain: A 24-week, randomized, double-blind, placebo-controlled study"
    Moran, Jose M.
    Leal-Hernandez, Olga
    Sanchez Fernandez, Antonio
    Pedrera-Zamorano, Juan D.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 214 : 194 - 195